Indication
Protocol Specific
24 clinical trials
37 products
10 drugs
Product
RRx-001Clinical trial
A Phase 1 Trial of RRx-001 in Combination With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System TumorsStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Product
IrinotecanProduct
TemozolomideClinical trial
An Open-Label, Multicenter, Dose Escalation And Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumor MalignanciesStatus: Terminated, Estimated PCD: 2022-11-01
Product
SHR-1916Clinical trial
A Phase 1, Open Label, First-in-human Study of TR1801-ADC, an Antibody Drug Conjugate (ADC), in Patients With Select Solid Tumors Expressing c-MetStatus: , Estimated PCD: 2023-07-04
Product
TR1801-ADCClinical trial
Phase 1/2 Modular Dose Escalation With Cohort Expansion of CP-506 (HAP) in Patients With Solid Tumor Types With High Incidence of HRD/FAD in Monotherapy or With Carboplatin or Patients With Solid Tumour and OPD Receiving ICIStatus: Recruiting, Estimated PCD: 2026-02-01
Product
CP-506Product
CarboplatinProduct
Immune checkpoint inhibitorClinical trial
Pilot Study: Detection of Carcinomas Using 64Cu-Labeled M5A Antibody to Carcinoembryonic Antigen (CEA)Status: Active (not recruiting), Estimated PCD: 2022-03-06
Clinical trial
A Phase I Trial of Epirubicin, Carboplatin and Capecitabine in Adult Cancer PatientsStatus: Completed, Estimated PCD: 2010-01-01
Drug
UTD1Drug
carboplatinProduct
EpirubicinProduct
Microarray AnalysisProduct
Polymorphism AnalysisClinical trial
Pilot Study of High-Dose Chemotherapy With Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent TumorsStatus: Active (not recruiting), Estimated PCD: 2013-01-19
Drug
busulfanClinical trial
A Phase I Clinical Trial of Sequential Pralatrexate Followed by a 48-hour Infusion of 5- Fluorouracil Given Every Other Week in Adult Patients With Solid TumorsStatus: Completed, Estimated PCD: 2015-02-04
Product
pralatrexateDrug
fluorouracilProduct
Polymerase Chain ReactionProduct
Nucleic acid sequencingClinical trial
A Phase I Study of Temozolomide, Oral Irinotecan, and Vincristine for Children With Refractory Solid TumorsStatus: Completed, Estimated PCD: 2009-06-01
Drug
temozolomideProduct
melphalanClinical trial
Tumor Genomic Profiling: A Personalized Medicine ApproachStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Mutation AnalysisProduct
VincristineClinical trial
Efficacy of Ondansetron Oral Soluble Film Combined With Dexamethasone Versus Ondansetron Intravenously Combined With Dexamethasone in Prophylaxis of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients : A Multi-center, Randomized, Parallel Controlled, Non-inferior Clinical Study.Status: Recruiting, Estimated PCD: 2026-07-01
Product
OndansetronProduct
TopotecanDrug
FilgrastimClinical trial
A Phase I Study to Determine the Dose of Methadone as a First Line Agent in the Treatment of Chronic Neuropathic Cancer PainStatus: Terminated, Estimated PCD: 2012-01-06
Product
MethadoneClinical trial
Phase I Study of Imatinib, Gemcitabine and Capecitabine in Patients With Solid TumorsStatus: Completed, Estimated PCD: 2009-01-30
Drug
capecitabineProduct
GemcitabineProduct
ImatinibProduct
Polymerase chain reactionClinical trial
A Phase I, Open-Label, Dose-Seeking Study of AZD2171 Given Daily Orally in Combination With Standard Chemotherapy Regimens (CT) in Patients With Advanced Incurable Non-Small Cell Lung Cancer (NSCLC) or Colorectal Cancer or Other Tumor Types Suitable for Treatment With CapecitabineStatus: Completed, Estimated PCD: 2009-10-23
Product
CediranibDrug
paclitaxelClinical trial
A Phase I Study of AT9283 Given As a 24 Hour Infusion on Days 1 and 8 Every Three Weeks in Patients With Advanced Incurable MalignancyStatus: Completed, Estimated PCD: 2010-04-09
Product
AT9283Clinical trial
A Phase I Study of AEG35156 Given as a 2 Hour Intravenous Infusion in Combination With Docetaxel in Patients With Solid TumoursStatus: Completed, Estimated PCD: 2009-03-24
Product
AEG35156Drug
docetaxelProduct
Protein Expression AnalysisClinical trial
A Phase I Study of AT7519M Given Twice Weekly in Patients With Advanced Incurable MalignancyStatus: Completed, Estimated PCD: 2012-03-13
Product
CDKI AT7519Clinical trial
A Phase I and Pharmacokinetics Study of Docetaxel in Combination With Capecitabine and Cisplatin in Solid TumorsStatus: Completed, Estimated PCD: 2009-11-01
Product
cisplatinClinical trial
A Phase I Clinical and Pharmacokinetic Study of SB939 in Patients With Advanced CancerStatus: Completed, Estimated PCD: 2010-04-22
Product
SB939Clinical trial
Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology SettingsStatus: , Estimated PCD: 2002-02-01
Product
nicotineClinical trial
A Phase I Study of a Second Generation Clusterin Antisense Oligonucleotide (OGX-011) in Combination With DocetaxelStatus: Completed, Estimated PCD: 2006-03-09
Product
CustirsenClinical trial
Double-Blind Randomized Trial of Methylphenidate for Alleviation of Fatigue and Lethargy Associated With Interferon Alpha 2bStatus: , Estimated PCD: 2002-05-01
Product
MethylphenidateProduct
BMS-247550Clinical trial
Research Factors Predictive of Treatment Failure With Erythropoietin Beta (NeoRecormon®) in Patients With Solid Tumors Treated With ChemotherapyStatus: Terminated, Estimated PCD: 2011-12-31
Product
Epoetin beta